{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:11Z","timestamp":1792787291693,"version":"4.5.0"},"reference-count":15,"publisher":"BMJ","issue":"6","funder":[{"name":"King's Medical Research Trust"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2022,3,4]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Faecal calprotectin (fCAL) is an established marker of intestinal inflammation in inflammatory bowel disease (IBD). Disproportionally high fCAL levels, for the severity of intestinal inflammation, have been previously observed in primary sclerosing cholangitis associated IBD (PSC-IBD). The aim of this study was to test the hypothesis that fCAL is a marker of biliary injury in PSC-IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used two cohorts: (1) post hoc analysis of a colonoscopic surveillance study allowing correlation of fCAL to endoscopic severity as measured by the ulcerative colitis endoscopic index of severity (UCEIS) in PSC-IBD (n=20) and ulcerative colitis (UC, n=20) and (2) prospective recruitment of patients attending for endoscopic retrograde cholangiopancreatography allowed the correlation of fCAL to biliary calprotectin (n=8).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A strong correlation was seen between fCAL and UCEIS in UC (r=0.821, 95%\u2009CI (0.585 to 0.929), p&lt;0.0001). In PSC-IBD, the correlation was weaker (r=0.596, 95%\u2009CI (0.195 to 0.8260), p=0.006). PSC-IBD patients with endoscopically quiescent colitis (UCEIS: 0\u20131) had higher fCAL than patients with UC (279\u2009\u00b5g\/g, IQR (68\u2013601) vs 30\u2009\u00b5g\/g, IQR (14\u2013107), p=0.015) . This was associated with higher risk of biliary complications like need for antibiotics or instrumentation (HR 16.39, 95%\u2009CI (2.98 to 90.25)) rather than colitis flares (follow-up: 12 months). Calprotectin measured in faeces correlated positively with biliary calprotectin (r=0.898, p=0.0024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>fCAL is a surrogate marker for biliary inflammation in PSC-IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02543021\">NCT02543021<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/flgastro-2021-102053","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:25:24Z","timestamp":1647609924000},"page":"497-502","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct02543021","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4864-2208","authenticated-orcid":false,"given":"Polychronis","family":"Pavlidis","sequence":"first","affiliation":[{"name":"Experimental Immunobiology, King's College London, London, UK"},{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9547-2809","authenticated-orcid":false,"given":"Deepak","family":"Joshi","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"},{"name":"Institute of Liver Studies, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"El Sherif","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"},{"name":"Institute of Liver Studies, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Warner","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"},{"name":"Institute of Liver Studies, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Gulati","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-327X","authenticated-orcid":false,"given":"James","family":"Alexander","sequence":"additional","affiliation":[{"name":"Imperial College London Faculty of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2705-4389","authenticated-orcid":false,"given":"Gemma","family":"Cross","sequence":"additional","affiliation":[{"name":"Biomarker Discovery, Viapath, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dew","sequence":"additional","affiliation":[{"name":"Biomarker Discovery, Viapath, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil Abu","family":"Arqoub","sequence":"additional","affiliation":[{"name":"Pathology Department, Viapath, King\u2019s College Hospital, London, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Devlin","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"},{"name":"Institute of Liver Studies, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5441-9064","authenticated-orcid":false,"given":"Michael","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dubois","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvar","family":"Bjarnason","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Powell","sequence":"additional","affiliation":[{"name":"Imperial College London Faculty of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-8815","authenticated-orcid":false,"given":"Bu'Hussain","family":"Hayee","sequence":"additional","affiliation":[{"name":"King's Institute of Therapeutic Endoscopy, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"2025090708500949000_13.6.497.1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34755"},{"key":"2025090708500949000_13.6.497.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.4.506"},{"key":"2025090708500949000_13.6.497.3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.4.506"},{"key":"2025090708500949000_13.6.497.4","doi-asserted-by":"publisher","DOI":"10.3109\/00365529209011186"},{"key":"2025090708500949000_13.6.497.5","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2013.816771"},{"key":"2025090708500949000_13.6.497.6","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.8523"},{"key":"2025090708500949000_13.6.497.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.022"},{"key":"2025090708500949000_13.6.497.8","first-page":"124","article-title":"Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence","volume":"32","author":"Mertz","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"2025090708500949000_13.6.497.9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ebiom.2015.08.041","article-title":"Contrasting pattern of chronic inflammatory bowel disease in primary and autoimmune sclerosing cholangitis","volume":"2","author":"Bjarnason","year":"2015","journal-title":"EBioMedicine"},{"key":"2025090708500949000_13.6.497.10","article-title":"A randomized crossover trial of conventional vs virtual Chromoendoscopy for colitis surveillance: dysplasia detection, feasibility, and patient acceptability (CONVINCE)","volume":"10","author":"Gulati","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2025090708500949000_13.6.497.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.024"},{"key":"2025090708500949000_13.6.497.12","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000069"},{"key":"2025090708500949000_13.6.497.13","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000000042","article-title":"Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis","volume":"48","author":"Voigtl\u00e4nder","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"2025090708500949000_13.6.497.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029821"},{"key":"2025090708500949000_13.6.497.15","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2012.011272"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2021-102053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:50:17Z","timestamp":1757260217000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2021-102053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,10,7]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/flgastro-2021-102053"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2021-102053","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}